This approach is also potent to differentiate the two models from GL261 and CT2A. Strengths ... The study only used intracranial injections of two mouse glioblastoma cell lines, which limits the ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
EU regulators have issued a positive opinion for the extension of the market authorization for subcutaneous formulation of ...
Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...
The Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for patients with solid tumors opened up ...
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological ...
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.
“When you inject yourself with, for example, insulin, you inject into subcutaneous fat, but these patients don’t have that,” ...
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, Wegovy, and Mounjaro. The research involved over two million patients and ...
Instead, he listed them on iPads handed to patients after they arrived, and instructed his employees never to take pictures of him performing injections, prosecutors said. When clients complained ...